# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-021605
Filing Date
2020-08-12
Accepted
2020-08-12 16:02:33
Documents
91
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0620_immucellcorp.htm | 10-Q | 1079614
2 | CERTIFICATION | f10q0620ex31_immucell.htm | EX-31 | 6670
3 | CERTIFICATION | f10q0620ex32_immucell.htm | EX-32 | 4225
| Complete submission text file | 0001213900-20-021605.txt |  | 6257246

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | iccc-20200630.xml | EX-101.INS | 1393034
5 | XBRL SCHEMA FILE | iccc-20200630.xsd | EX-101.SCH | 60430
6 | XBRL CALCULATION FILE | iccc-20200630_cal.xml | EX-101.CAL | 66033
7 | XBRL DEFINITION FILE | iccc-20200630_def.xml | EX-101.DEF | 176110
8 | XBRL LABEL FILE | iccc-20200630_lab.xml | EX-101.LAB | 426339
9 | XBRL PRESENTATION FILE | iccc-20200630_pre.xml | EX-101.PRE | 326566

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 201095446
SIC: 2835 In Vitro & In Vivo Diagnostic Substances